Steven Hochwald, MD, FACS

Steven Hochwald, MD, FACS

Roswell Park Cancer Institute
Chief of Gastrointestinal Surgery
Vice Chair of Department of Surgical Oncology
Professor of Oncology
Areas of Expertise: 
Colorectal cancer
Esophageal cancer
Liver cancer
Pancreatic cancer
Small intestine cancer
Stomach cancer
Special Interests: 
Design, synthesis and evaluation of novel selective inhibitors of FAK and IGF-1R function in cancer.
Targeted, image guided release of combinatorial FAK inhibitors in pancreatic cancer.
Novel agents that target FAK and IGF-1R protein interactions.
FAK and IGF-1R interactions in pancreatic cancer survival.
Nanoparticle directed therapy for GI malignancy.
Technical advances in minimally invasive esophagectomy and minimally invasive gastr.ectomy
Outcomes for patients undergoing surgical therapy for upper gastrointestinal cancers.
Board Certification: 
1998: American Board of Surgery, recertification: 2008
Fellowship: 
1997-1999: Memorial Sloan-Kettering Cancer Center, Department of Surgery
1993-1995: Memorial Sloan-Kettering Cancer Center, Surgical Metabolism Laboratory, under Michael Burt, M.D., Ph.D., and Murray F. Brennan, M.D.
Residency: 
1996-1997: Executive Chief Resident: New York University Medical Center, Department of Surgery
1991-1996: Resident, New York University Medical Center, Categorical General Surgery Housestaff in Department of Surgery
Education and Training: 
MD, New York University School of Medicine